CARM1 and non-small cell lung carcinoma: In addition, Wu D et al. observed that both CARM1 and CCNE2 were highly associated with shorter 10-year overall survival rates of at a large cohort of 461 cases of NSCLC patients and that CARM1 could promote NSCLC progression via the activation of CCNE2 [25].